Top Markets
#1 MowCat MowCat +775.59%
#2 龙虾 (Lobster) 龙虾 (Lobster) +81.18%
#3 Akedo Akedo +43.02%
#4 Magma Finance Magma Finance +42.54%
#5 SIXSEVEN SIXSEVEN +28.89%
#6 MarsCoin MarsCoin +27.75%
#7 DeXe DeXe +27.23%
#8 Cortex Cortex +25.74%
#9 Staked ZIG Staked ZIG +16.36%
#10 Zignaly Zignaly +16.25%
Coin of the day
MowCat MowCat
설정
언어
한국어
통화
USD
테마
Staidson (Beijing) BioPharmaceuticals Co., Ltd. Staidson (Beijing) BioPharmaceuticals Co., Ltd.

Staidson (Beijing) BioPharmaceuticals Co., Ltd.

300204
주식 순위 #7949
Staidson (Beijing) BioPharmaceuticals Co., Ltd. is a Chinese biopharmaceutical... Staidson (Beijing) BioPharmaceuticals Co., Ltd. is a Chinese biopharmaceutical company that specializes in the entire lifecycle of therapeutic drugs, from research and development to production and market distribution. Their product portfolio encompasses a variety of drug types, including advanced protein-based medicines like therapeutic monoclonal antibodies, innovative gene and cell therapies, and conventional chemical pharmaceuticals. The company's primary therapeutic areas address conditions related to the nervous system, infectious diseases, gastrointestinal health, the urinary system, and autoimmune disorders. Notably, Staidson has established a strategic partnership with Pivotal S.L. to conduct clinical trials in Europe for BDB-001, a monoclonal anti-C5a antibody, aimed at treating patients with severe, progressive COVID-19 caused by the SARS-CoV-2 virus. Founded in 2002, the company's headquarters are located in Beijing, China.
주가
$3.11
시가총액
$1.41B
변동 (1일)
-1.97%
변동 (1년)
-57.22%
국가
CN
거래 Staidson (Beijing) BioPharmaceuticals Co., Ltd. (300204)

카테고리

Healthcare
Staidson (Beijing) BioPharmaceuticals Co., Ltd. (300204)의 수익
2026 기준 수익 TTM: 0
Staidson (Beijing) BioPharmaceuticals Co., Ltd.의 최신 재무 보고서에 따르면 회사의 현재 수익은 0입니다. 2026년에 회사는 0의 수익을 올렸으며 이는 2026년의 수익 0과 동일입니다. 이 페이지에 표시된 수익은 이자 및 세금 공제 전 수익으로, 즉 EBIT입니다.
Staidson (Beijing) BioPharmaceuticals Co., Ltd.의 수익 기록 (2026 ~ 2026)
연말 수익
연도 수익 변화
제공된 날짜에 대한 데이터가 충분하지 않습니다.
유사 기업 또는 경쟁사의 수익
회사 수익 수익 차이 국가
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
$5.27B -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
$1.95B -
NL
CSL Limited CSL Limited
CSL Limited
CSL.AX
$-4.02B -
AU
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
$-3.09B -
US
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
- -
CH